Different Treatment Approaches for Carpal Tunnel Syndrome
Launched by SAKARYA UNIVERSITY · Jun 24, 2025
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying different ways to treat carpal tunnel syndrome, a condition that causes numbness, tingling, and pain in the hand and fingers because a nerve in the wrist is being squeezed. The study will compare three treatments: wearing a special wrist brace (called an orthosis) that keeps the wrist in a resting position, receiving physical therapy that includes electrical stimulation, heat packs, and exercises, or a combination of both the brace and physical therapy. The goal is to see which treatment helps the most with daily activities, reducing pain, improving grip strength, and overall quality of life, as well as how satisfied patients feel with their treatment.
To take part, you need to be between 18 and 65 years old and have been diagnosed with mild to moderate carpal tunnel syndrome. People who have had symptoms for more than a year, had surgery or recent physical therapy for carpal tunnel, steroid injections, wrist injuries, or other health problems affecting their symptoms won’t be eligible. If you join the study, you’ll be placed in one of the three groups and will follow the treatment assigned to that group. This study is not yet recruiting participants but aims to find the best approach to help people with carpal tunnel syndrome feel better and improve their hand function.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Be between the ages of 18 and 65
- • Have been diagnosed with mild or moderate carpal tunnel syndrome
- Exclusion Criteria:
- • Symptom duration of more than 12 months,
- • Those who have undergone surgery for carpal tunnel syndrome
- • Those who have received physical therapy within the last 6 months,
- • Those who have received steroid injections into the carpal tunnel,
- • Those with a history of trauma to the wrist and surrounding area,
- • Those using non-steroidal anti-inflammatory drugs,
- • Individuals with additional systemic, musculoskeletal, or neurological conditions that may affect symptoms will be excluded from the study.
About Sakarya University
Sakarya University is a distinguished academic institution dedicated to advancing scientific research and innovation in healthcare. With a robust commitment to improving patient outcomes, the university actively sponsors clinical trials that explore novel therapeutic approaches and contribute to evidence-based medicine. Leveraging a multidisciplinary team of researchers, clinicians, and scholars, Sakarya University fosters a collaborative environment aimed at enhancing clinical practices and addressing pressing health challenges. Through these initiatives, the university not only enriches the academic landscape but also plays a pivotal role in translating research findings into tangible benefits for society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Emel TAŞVURAN HORATA
Principal Investigator
Sakarya University of Applied Sciences
Gizem Nur ÇALIŞIR
Study Chair
Sakarya University of Applied Sciences
Nimet UÇAROĞLU CAN
Study Chair
Sakarya University
Sinem AKTAŞ
Study Chair
Sakarya University of Applied Sciences
Tülay KARSLI
Study Chair
Sakarya University of Applied Sciences
Ayşenur Yaren BÜRTEK
Study Chair
Sakarya University of Applied Sciences
Emre Uzun
Study Chair
Sakarya University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported